Cargando…
Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
(R,S)-ketamine elicits rapid-acting and sustained antidepressant actions in treatment-resistant patients with depression. (R)-ketamine produces longer-lasting antidepressant effects than (S)-ketamine in rodents; however, the precise molecular mechanisms underlying antidepressant actions of (R)-ketam...
Autores principales: | Yao, Wei, Cao, Qianqian, Luo, Shilin, He, Lujuan, Yang, Chun, Chen, Jiaxu, Qi, Qi, Hashimoto, Kenji, Zhang, Ji-chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095473/ https://www.ncbi.nlm.nih.gov/pubmed/34819637 http://dx.doi.org/10.1038/s41380-021-01377-7 |
Ejemplares similares
-
Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
por: Yao, Wei, et al.
Publicado: (2021) -
Activation of BDNF by transcription factor Nrf2 contributes to antidepressant-like actions in rodents
por: Yao, Wei, et al.
Publicado: (2021) -
A BDNF Val66Met Polymorphism and Ketamine-induced Rapid Antidepressant Action
por: Hashimoto, Kenji
Publicado: (2012) -
PKA-CREB-BDNF signaling regulated long lasting antidepressant activities of Yueju but not ketamine
por: Xue, Wenda, et al.
Publicado: (2016) -
Essential role of microglial transforming growth factor-β1 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-β1
por: Zhang, Kai, et al.
Publicado: (2020)